Skip to main content
PepStack
Blutwerte · Marker

Omega-3-Index

Omega-3 Index · EPA+DHA Index · Fatty Acid Status

Vitamine & NährstoffeNüchtern erforderlich
Einheit:
%
Abbreviation
Omega-3 Index

The Omega-3 Index quantifies the percentage of EPA and DHA in the red blood cell membranes.

Reference Ranges

Reference
48%
4
8
11
8
LowNormalHigh
Reference
Optimal
Unit · %

Ranges may vary based on population dietary habits and genetic factors.

Overview

Übersicht

The Omega-3 Index is a biomarker that measures the percentage of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the red blood cell (RBC) membrane fatty acids. This index reflects the long-term dietary intake of omega-3 fatty acids and is considered a reliable indicator of an individual's omega-3 status. Researchers use this index to assess the risk of various health conditions and to monitor the efficacy of omega-3 supplementation. Clinically, the Omega-3 Index is important for evaluating cardiovascular health, as low levels have been associated with an increased risk of sudden cardiac death (SCD) and other cardiovascular diseases. It is also linked to brain health, with lower levels correlating with increased risks of psychiatric disorders, cognitive decline, and dementia. The index is particularly relevant for athletes and biohackers, as optimal levels of omega-3 fatty acids may support improved brain function, reduced inflammation, and enhanced recovery. However, it is important to consider potential confounders such as dietary habits, genetic factors, and the presence of other fatty acids that may influence the index. Testing is typically performed on fasting samples, and results can be affected by recent dietary intake or supplementation. Therefore, consistent testing conditions are recommended for accurate monitoring.

Klinische Bedeutung

Elevated Omega-3 Index values are generally associated with a reduced risk of cardiovascular diseases and improved brain health. Conversely, reduced values may indicate an increased risk of sudden cardiac death, cognitive decline, and psychiatric disorders.

Dynamics

Trend Interpretation

Rising Values

Progressively rising values suggest improved cardiovascular and cognitive health. Re-test annually to monitor status.

Falling Values

Progressively falling values may indicate increased risk of cardiovascular issues and cognitive decline.

Re-test Interval

6 months if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • High fish oil supplementation
  • High dietary intake of fatty fish
  • Genetic predisposition
  • Use of omega-3 enriched foods
Cause

Low Levels

  • Low dietary intake of omega-3
  • High intake of omega-6 fatty acids
  • Poor absorption of fats
  • Metabolic disorders
Protocol

How to Optimize

Lever

Lifestyle

  • Increase physical activity
  • Reduce stress levels
Lever

Nutrition

  • Consume more fatty fish like salmon and mackerel
  • Include flaxseeds and walnuts in diet
Lever

Supplementation

  • Fish oil supplements
  • Algal oil supplements

Note:

Consult a healthcare provider before starting any supplementation, especially if you have underlying health conditions.

Testing Guidelines

🍽️Fasting Required
Not Time-Sensitive

Testing Frequency

Annually for healthy adults, more frequently if managing specific health conditions

Interfering Factors

  • Recent dietary changes
  • Omega-3 supplementation
  • Inflammatory conditions

Open Research Questions

Current research suggests that there is no consensus on optimal Omega-3 Index reference ranges or target values for various psychiatric conditions, particularly for major depression and dementia. Researchers have not yet established the impact of confounding factors such as dietary habits and genetic predispositions on Omega-3 Index levels. Additionally, clinical questions remain unanswered regarding the efficacy of specific EPA and DHA formulations in improving mental health outcomes and the long-term implications of varying Omega-3 Index levels.

20 Research Publications

651

Total Citations

11

Human/RCT

4.9

Avg. Influence

2024

Latest

Sort
Filter
#01

The omega-3 index: clinical utility for therapeutic intervention.

ReviewInfluence8.0
141
Researchers explored the clinical utility of the Omega-3 Index in assessing cardiovascular risk. They found that low Omega-3 levels are associated with increased risk for sudden cardiac death. The study advocates for using the Omega-3 Index as both a risk marker and a risk factor in clinical settings.
View on PubMed
#02

The omega-3 index: from biomarker to risk marker to risk factor.

ReviewInfluence8.0
137
This review examined the Omega-3 Index as a potential risk marker for coronary heart disease. Researchers found that lower Omega-3 Index levels are linked to increased risk for coronary heart disease, particularly sudden cardiac death. The study suggests that the Omega-3 Index meets many criteria for being classified as a risk factor.
View on PubMed
#03

Importance of EPA and DHA Blood Levels in Brain Structure and Function.

von Schacky Clemens · Nutrients · 2021

ReviewInfluence6.0
136
Researchers examined the relationship between blood levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and brain health. They found that lower Omega-3 Index levels were associated with increased risks for mortality, ischemic stroke, and cognitive decline. The study suggests that future trials should focus on using the Omega-3 Index to guide EPA and DHA supplementation.

Key findings

  1. 01Researchers observed that adequate blood levels of EPA and DHA are essential for brain health.
  2. 02Researchers found that dietary intake significantly affects the levels of these fatty acids in the blood.
  3. 03Researchers noted that the HS-Omega-3 Index is a reliable method for assessing EPA and DHA levels.
View on PubMed
#04

Omega-3 world map: 2024 update.

Schuchardt Jan Philipp, et al. · Progress in lipid research · 2024

HumanInfluence4.0
69
This study updated the 2016 worldwide Omega-3 Index (O3I) map, analyzing data from 328 studies with over 342,000 subjects. Researchers found that most countries had low to very low O3I levels, with notable improvements in some countries since 2016. Countries like Iran, Egypt, and India exhibited particularly poor O3I levels.

Key findings

  1. 01Researchers observed that the USA, Canada, Italy, Turkey, UK, Ireland, and Greece improved from very low to low omega-3 levels.
  2. 02Researchers noted that France, Spain, and New Zealand moved from low to moderate levels.
  3. 03Researchers found that countries like Iran, Egypt, and India had particularly poor omega-3 levels.
View on PubMed
#05

Cardiovascular risk and the omega-3 index.

ReviewInfluence5.0
53
This study proposed the Omega-3 Index as a potential risk factor for sudden cardiac death (SCD). Researchers observed a correlation between Omega-3 Index levels and SCD risk, suggesting that higher levels of EPA and DHA could reduce the incidence of SCD. The study emphasizes the importance of monitoring Omega-3 levels for cardiovascular health.
View on PubMed
#06

Estimation and predictors of the Omega-3 Index in the UK Biobank.

HumanInfluence2.0
21
This study aimed to estimate the Omega-3 Index in the UK Biobank population. Researchers developed an equation to predict the Omega-3 Index based on plasma measurements and found a mean Omega-3 Index of 5.58%. The study identified several demographic and lifestyle factors that correlated with Omega-3 Index levels.
View on PubMed
#07

Cardiovascular disease prevention and treatment.

ReviewInfluence1.0
21
This article reviewed the relationship between Omega-3 Index levels and cardiovascular disease risks. Researchers found that a lower Omega-3 Index was associated with a tenfold increase in the risk of sudden cardiac death. The study emphasizes the importance of assessing Omega-3 levels to predict cardiovascular health.
View on PubMed
#08

Requisite Omega-3 HUFA Biomarker Thresholds for Preventing Murine Lupus Flaring.

Animal
17
In studies on lupus, researchers found that higher Omega-3 Index levels were associated with reduced indicators of autoimmune activity. They identified thresholds for Omega-3 levels that could be targeted in future human studies to potentially lessen lupus symptoms. The findings suggest a link between Omega-3 consumption and autoimmune disease management.
View on PubMed
#09

The omega-3 index in patients with heart failure: A prospective cohort study.

Human
15
In a cohort study of heart failure patients, researchers observed that the Omega-3 Index was markedly low and did not predict mortality risk. The study indicated weak associations between Omega-3 levels and various clinical characteristics of heart failure, suggesting further research is needed to clarify these relationships.
View on PubMed
#10

Omega-3 Index as a Sport Biomarker: Implications for Cardiovascular Health, Injury Prevention, and Athletic Performance.

Review
12
Researchers discussed the implications of the Omega-3 Index in sports medicine. They found that maintaining optimal Omega-3 levels may benefit cardiovascular health, recovery, and injury prevention in athletes. The study highlights the potential of the Omega-3 Index as a biomarker for athletic performance.
View on PubMed

Publication Trend

Research publications about Omega-3-Index over time

10total
1
'07
1
'09
1
'10
1
'21
1
'22
1
'23
2
'24
1
'25
1
'26

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer